Profile
Christopher Martin currently works at Orum Therapeutics, Inc., as Head-Legal.
Mr. Martin also formerly worked at LeMaitre Vascular, Inc., as Corporate Counsel from 2006 to 2008, athenahealth, Inc., as Assistant General Counsel from 2012 to 2014, and AquaBounty Technologies, Inc., as General Counsel in 2015.
Mr. Martin received his undergraduate degree from Stanford University and doctorate degree from the University of California.
Christopher Martin active positions
| Companies | Position | Start |
|---|---|---|
| ORUM THERAPEUTICS, INC. | General Counsel | - |
Former positions of Christopher Martin
| Companies | Position | End |
|---|---|---|
| ATHENAHEALTH, INC | General Counsel | 2011-12-31 |
| LEMAITRE VASCULAR, INC. | General Counsel | 2007-12-31 |
| AQUABOUNTY TECHNOLOGIES, INC. | General Counsel | - |
Training of Christopher Martin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. Medical SpecialtiesHealth Technology Designs and manufactures vascular devices for vascular surgeons | Health Technology |
athenahealth, Inc.
athenahealth, Inc. Packaged SoftwareTechnology Services Develops AI platform for ambulatory healthcare practices | Technology Services |
AquaBounty Technologies, Inc.
AquaBounty Technologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on improving productivity in commercial aquaculture | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orum Therapeutics, Inc.
Orum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that engages in the research and development of pharmaceuticals for cancer and immune diseases | Health Technology |
- Stock Market
- Insiders
- Christopher Martin
















